Table 1.

Costs of innate and acquired immune defenses

	Costs				Effectiveness
	Developmental	Maintenance	Activation	Collateral damage	Novel/primary exposures	Secondary/ future exposures
Innate immunity	low	medium	high	medium	good	good
Acquired immunity	very high	low	low	low	poor	excellent

Source: adapted from Klasing (1999).